Mohammad Shehata, I.; Masood, W.; Nemr, N.; Anderson, A.; Bhusal, K.; Edinoff, A.N.; Cornett, E.M.; Kaye, A.M.; Kaye, A.D.
The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease. Neurol. Int. 2022, 14, 310-321.
https://doi.org/10.3390/neurolint14020025
AMA Style
Mohammad Shehata I, Masood W, Nemr N, Anderson A, Bhusal K, Edinoff AN, Cornett EM, Kaye AM, Kaye AD.
The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease. Neurology International. 2022; 14(2):310-321.
https://doi.org/10.3390/neurolint14020025
Chicago/Turabian Style
Mohammad Shehata, Islam, Waniyah Masood, Nouran Nemr, Alexandra Anderson, Kamal Bhusal, Amber N. Edinoff, Elyse M. Cornett, Adam M. Kaye, and Alan D. Kaye.
2022. "The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease" Neurology International 14, no. 2: 310-321.
https://doi.org/10.3390/neurolint14020025
APA Style
Mohammad Shehata, I., Masood, W., Nemr, N., Anderson, A., Bhusal, K., Edinoff, A. N., Cornett, E. M., Kaye, A. M., & Kaye, A. D.
(2022). The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease. Neurology International, 14(2), 310-321.
https://doi.org/10.3390/neurolint14020025